Optiscan Imaging Limited (ASX:OIL)
Australia · Delayed Price · Currency is AUD 0.0880
+0.0020 (2.33%)
Aug 29, 2025, 3:37 PM AEST
Optiscan Imaging Company Description
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States.
It offers InVivage, an intra-oral endomicroscope for oral cancer imaging; InVue, a microscopic medical imaging device for precision surgery; and ViewnVivo, an endomicroscope for life sciences, pre-clinical and translational research.
The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery.
Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Optiscan Imaging Limited
| Country | Australia |
| Founded | 1994 |
| Industry | Scientific & Technical Instruments |
| Sector | Technology |
| Employees | 9 |
| CEO | Camile Farah |
Contact Details
Address: 16 Miles Street Mulgrave, 3170 Australia | |
| Phone | 61 3 9538 3333 |
| Website | optiscan.com |
Stock Details
| Ticker Symbol | OIL |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000OIL4 |
| SIC Code | 3827 |
Key Executives
| Name | Position |
|---|---|
| Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. | Chief Executive Officer, MD, President and Executive Director |
| Darius Ooi | Chief Financial Officer |
| Dr. Sanchitha Fernando | Chief Technology Officer |
| Kaylene Dawson | General Counsel |
| Belinda Williamson | Chief Commercial Officer |
| Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAIC | Company Secretary |